Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Alpha-1-acid glycoprotein measurement

Known as: A1AGLP, Alpha-1 Acid Glycoprotein, Alpha-1 Acid Glycoprotein Measurement 
The determination of the amount of alpha-1 acid glycoprotein present in a sample.
National Institutes of Health

Related topics

Related topics

4 relations
Alpha-1-Acid Glycoprotein 1, humanCDISC SDTM Laboratory Test Terminology by CodeCDISC SDTM Laboratory Test Terminology by NameClinical Data Interchange Standards Consortium Terminology

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Interaction of new kinase inhibitors cabozantinib and tofacitinib with human serum alpha-1 acid glycoprotein. A comprehensive spectroscopic and molecular Docking approach.
In the current study we have investigated the interaction of newly approved kinase inhibitors namely Cabozantinib (CBZ) and… Expand
Highly Cited
2013
Highly Cited
2013
A physiologically based pharmacokinetic (PBPK) approach to evaluate pharmacokinetics in patients with cancer
Potential differences in pharmacokinetics (PK) between healthy subjects and patients with cancer were investigated using a… Expand
2010
2010
Lopinavir protein binding in HIV‐1‐infected pregnant women
Pregnancy may alter protein binding (PB) of highly bound protease inhibitors due to changes in plasma concentrations of albumin… Expand
2004
2004
Selectivity in the binding of psychotropic drugs to the variants of alpha-1 acid glycoprotein
SummaryThe S- and F-forms of alpha-1 acid glycoprotein (AAG) variants have been isolated by isoelectric focusing with immobilines… Expand
  • figure 1
  • figure 2
  • table 1
  • table 2
Highly Cited
2001
Highly Cited
2001
Pharmacokinetics of Bupivacaine after Continuous Epidural Infusion in Infants with and without Biliary Atresia
BackgroundContinuous epidural infusion of bupivacaine is widely practiced for postoperative pain relief in pediatric patients… Expand
1998
1998
The genetic variant A of human alpha 1-acid glycoprotein limits the blood to brain transfer of drugs it binds.
The objective of this work was to check the effects of alpha-1 acid glycoprotein (AAG) and of its components, A and F1/S genetic… Expand
1997
1997
Incomplete or absent acute phase response in some postoperative patients.
In a prospective study, 74 patients were admitted for an open fracture of the lower limb and treated by osteosynthesis. None of… Expand
1994
1994
Transcriptional activation of the alpha-1 acid glycoprotein gene by YY1 is mediated by its functional interaction with a negative transcription factor.
Regulation of alpha-1 acid glycoprotein (AGP) gene expression involves both positive and negative transcription factors. We have… Expand
1988
1988
Catecholamine binding and concentrations in acute phase plasma after surgery.
The present study was undertaken to decide whether the bound fractions and/or total concentrations of catecholamines were… Expand
1987
1987
Binding of catecholamines to alpha-1 acid glycoprotein, albumin and lipoproteins in human serum.
The binding of catecholamines in human serum was determined by equilibrium dialysis at 37 degrees. For serum concentrations of 10… Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE